Nigel Austin

1.9k total citations
24 papers, 727 citations indexed

About

Nigel Austin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Nigel Austin has authored 24 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Nigel Austin's work include Receptor Mechanisms and Signaling (9 papers), Neuroscience and Neuropharmacology Research (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Nigel Austin is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuroscience and Neuropharmacology Research (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Nigel Austin collaborates with scholars based in United Kingdom, Belgium and United States. Nigel Austin's co-authors include Philip D. Jeffrey, Michael S. Hadley, Frederik Rombouts, Andrés A. Trabanco, Gary Tresadern, Kevin M. Thewlis, Geoffrey Stemp, Fulgencio Tovar, Declan N.C. Jones and Mikhail Kalinichev and has published in prestigious journals such as Journal of Medicinal Chemistry, Epilepsia and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Nigel Austin

23 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nigel Austin United Kingdom	14	329	253	165	134	104	24	727
Emmanuel Pinard Switzerland	20	545 1.7×	321 1.3×	385 2.3×	168 1.3×	136 1.3×	44	1.3k
Silvio Ofner Switzerland	18	449 1.4×	425 1.7×	135 0.8×	199 1.5×	107 1.0×	28	839
Martyn C. Coldwell United Kingdom	14	347 1.1×	308 1.2×	84 0.5×	131 1.0×	109 1.0×	24	632
Michael S. Hadley United Kingdom	16	472 1.4×	277 1.1×	494 3.0×	118 0.9×	112 1.1×	55	1.0k
Henner Knust Switzerland	16	279 0.8×	206 0.8×	509 3.1×	146 1.1×	65 0.6×	25	977
Wei Lemaire United States	16	784 2.4×	881 3.5×	122 0.7×	189 1.4×	96 0.9×	25	1.2k
Tatsuki Koike Japan	14	197 0.6×	100 0.4×	229 1.4×	68 0.5×	76 0.7×	41	642
Andres D. Ramirez United States	13	332 1.0×	219 0.9×	91 0.6×	66 0.5×	97 0.9×	16	798
Pete H. Hutson United States	12	315 1.0×	319 1.3×	88 0.5×	116 0.9×	32 0.3×	17	598
Frank Brown United Kingdom	15	399 1.2×	187 0.7×	357 2.2×	145 1.1×	140 1.3×	30	1.0k

Countries citing papers authored by Nigel Austin

Since Specialization

Citations

This map shows the geographic impact of Nigel Austin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Austin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Austin more than expected).

Fields of papers citing papers by Nigel Austin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Austin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Austin. The network helps show where Nigel Austin may publish in the future.

Co-authorship network of co-authors of Nigel Austin

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Austin. A scholar is included among the top collaborators of Nigel Austin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Austin. Nigel Austin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Austin, Nigel, et al.. (2025). Preclinical pharmacokinetics, metabolism, and disposition of NXE0041178, a novel orally bioavailable agonist of the GPR52 receptor with potential for treatment of schizophrenia and related psychiatric disorders. Xenobiotica. 55(3). 151–166.

Austin, Nigel, Rachel Armstrong, Alícia P. Higueruelo, et al.. (2023). The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric Disorders. ACS Medicinal Chemistry Letters. 14(4). 499–505. 9 indexed citations

Peschiulli, Aldo, Daniel Oehlrich, Michiel Van Gool, et al.. (2021). A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo. ACS Medicinal Chemistry Letters. 13(1). 76–83. 7 indexed citations

Oehlrich, Daniel, Aldo Peschiulli, Gary Tresadern, et al.. (2019). Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine Warheads. ACS Medicinal Chemistry Letters. 10(8). 1159–1165. 26 indexed citations

Bischoff, François, Serge Pieters, Didier Berthelot, et al.. (2019). Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 29(14). 1737–1745. 6 indexed citations

Lu, Tianbao, Peter J. Connolly, Ulrike Philippar, et al.. (2019). Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease. Bioorganic & Medicinal Chemistry Letters. 29(23). 126743–126743. 9 indexed citations

Gijsen, Harrie J. M., Gregor J. Macdonald, Daniel Oehlrich, et al.. (2018). Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate. Journal of Medicinal Chemistry. 61(12). 5292–5303. 11 indexed citations

Schneider, Eric L., Gary W. Ashley, Lieve Dillen, et al.. (2015). Half-life extension of the HIV-fusion inhibitor peptide TRI-1144 using a novel linker technology. European Journal of Pharmaceutics and Biopharmaceutics. 93. 254–259. 6 indexed citations

Kalinichev, Mikhail, Adam Lucas, Simon T. Bate, et al.. (2010). Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NK1‐receptor antagonist in the rat. Epilepsia. 51(8). 1543–1551. 10 indexed citations

10.

Large, Charles H., Mikhail Kalinichev, Adam Lucas, et al.. (2009). The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the rat. Epilepsy Research. 85(1). 96–106. 36 indexed citations

11.

Kalinichev, Mikhail, Melanie J. Robbins, Elizabeth M. Hartfield, et al.. (2007). Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague–Dawley rats: A locomotor activity and gene induction study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(2). 414–422. 65 indexed citations

12.

Austin, Nigel, Michael S. Hadley, John D. Harling, et al.. (2003). The design of 8,8-Dimethyl[1,6]naphthyridines as potential anticonvulsant agents. Bioorganic & Medicinal Chemistry Letters. 13(10). 1627–1629. 22 indexed citations

13.

Porter, Roderick A., Wai N. Chan, Steven Coulton, et al.. (2001). 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorganic & Medicinal Chemistry Letters. 11(14). 1907–1910. 119 indexed citations

14.

Austin, Nigel, Leanne Cutler, Nigel Deeks, et al.. (2001). Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey:in vitro/in vivocorrelation and the role of aldehyde oxidase. Xenobiotica. 31(8-9). 677–686. 52 indexed citations

15.

Austin, Nigel, Kim Y. Avenell, Izzy Boyfield, et al.. (2001). Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 11(5). 685–688. 13 indexed citations

16.

Austin, Nigel, et al.. (2001). The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.. PubMed. 29(4 Pt 1). 435–42. 19 indexed citations

17.

Roberts, C., Jim J. Hagan, Nigel Austin, et al.. (2000). The effect of SB-236057-A, a selective 5-HT 1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig. Naunyn-Schmiedeberg s Archives of Pharmacology. 362(2). 177–183. 22 indexed citations

18.

Austin, Nigel, Kim Y. Avenell, Izzy Boyfield, et al.. (2000). Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 10(22). 2553–2555. 15 indexed citations

19.

Austin, Nigel, Kim Y. Avenell, Izzy Boyfield, et al.. (1999). Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 9(2). 179–184. 15 indexed citations

20.

Clarke, S. E., Nigel Austin, J. C. Bloomer, et al.. (1994). Metabolism and disposition of¹⁴C-granisetron in rat, dog and man after intravenous and oral dosing. Xenobiotica. 24(11). 1119–1131. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact